Observed Signal · Aug 21, 2026 · Funding · Source: AINews swyx · Impact: 4/5 · Sentiment: Positive
Simile AI: Behavioral Simulation and Scaling Laws
This podcast episode with Simile co-founder and CEO Joon Sung Park explores the company's work building behavioral foundation models and synthetic populations for simulation. Simile has raised over $300 million at a $2 billion valuation, backed by a recent Series B. The company creates digital twins from interviews, transaction/observational data, and randomized controlled trials, enabling enterprise clients like CVS Health to test policies on simulated populations. In a 1,000-person study, digital twins reproduced human behavior about 85% as accurately as the originals. Simile has partnered with Gallup to access tens of millions of real human subjects, and aims to scale from market research and legal strategy to societal-level simulations of 'wicked problems' like climate change. The episode also discusses the company's multi-agent simulations and its long-term vision.
Validated academic results (1,000-person study with ~85% accuracy), enterprise deployments (Fortune 100 clients like CVS), and a major Series B valuation signal accelerating adoption of simulation-based behavioral models that could reshape market research and product testing.
Track Greenoaks Signals & Market Shifts in Real-Time
Polaris7 autonomous intelligence agents track regulatory filings, primary sources, executive changes, and deal flow 24/7. Create your Polaris7 workspace to monitor these entities.
Key Takeaways & Evidence Grounding
- Simile has raised over $300 million at a $2 billion valuation (reported Series B).
- Simile creates digital twins of real people from interviews and behavioral data, used by Fortune 100 clients like CVS.
- In a representatively sampled 1,000-person study, Simile's digital twins reproduced human behavior about 85% as accurately as the original humans.
- Simile has a strategic partnership with Gallup, providing access to 30-40 million real human subjects.
- Simile builds behavioral foundation models using interview data, observational/transaction data, and randomized controlled trials, with post-training on causal mechanisms.
Connected Companies & Entities
11 Entities mapped“Simile AI's $2B Series B, backed by GreenOaks and Index Ventures with prominent backers like Fei-Fei Li and Andrej Karpathy...”
“Simile AI's $2B Series B, backed by GreenOaks and Index Ventures with prominent backers like Fei-Fei Li and Andrej Karpathy...”
“We do, have a strategic partnership with Gallup, and of course, Gallup is deep into policy space and so forth.”
“For listeners, we covered a similar topic with Mikhail Parakhin from Shopify, where they are working on SimGym.”
“Simile AI's $2B Series B ... (linked to TechCrunch coverage of the funding).”
“CVS Health can test a new pricing policy against thousands of simulated patients.”
“Many of the members are from Figma, Notion, Rive, and so forth, but also more broadly from the companies that we as a team have really admir...”
“15%, almost 20% of the company population are just my lab mates from Microsoft Research lab.”
“Many of the members are from Figma, Notion, Rive, and so forth, but also more broadly from the companies that we as a team have really admir...”
“OpenAI, or I think Sam Altman funded a study on this ... (discussion referencing OpenAI-funded research and experiments).”
“In security industry, if you look at companies like Wiz, you’re fundamentally trying to prevent things that have not happened yet.”
Ontology Mapping & Concepts
Related Market Signals & Shifts
Recent verified developments and strategic activity across this market segment.
Simile Raises $200M Series B at $2B Valuation
Simile, a startup that builds synthetic/simulated users for marketing and product research, raised $200 million in a Series B at a $2 billion valuation. The round, announced July 30, 2026, was led by Greenoaks with participation from Index Ventures, Hanabi, Bain Capital Ventures, A*, Factory, Definition and CVS Health Ventures. The raise comes five months after Simile's $100 million Series A led by Index. Simile was founded by Joon Sung Park and counts CVS among its customers. The company positions its technology as a way to simulate user behavior for research and product testing, attracting growing VC interest in the synthetic-user market.
Startups Aim to Make AI More Human
A wave of early-stage startups is building AI agents designed to simulate human emotions, intentions and behavior. Simile raised a $100 million round led by Index partner Shardul Shah after training models on recorded conversations and behavioral-science data to predict emotional reactions. New ventures named in the piece include Prior Computers (founded by researchers from MIT and Harvard), People Make Things (stealth, focused on intent prediction), Aaru (valued near $1 billion in a recent round led by Redpoint), Humans& (founders from Google, Anthropic and xAI with $480 million of backing), Expected Parrot (an open-source interview dataset), and Constellation Systems (seeded to build a foundation model of “human state”). The coverage highlights investor momentum and varied technical approaches to modeling human-like responses for applications such as market research, customer simulation and collaboration tools.
Simulation Is Supplanting Human Roles in AI Pipelines
The Latent Space AINews newsletter (published 2026-08-22) argues that AI development is rapidly shifting from human-created components to model-generated simulation — cheaper, faster, and slightly lower quality but verifiable. The piece synthesizes recent research and product activity: model-written reward/judging systems (InstructGPT, Constitutional AI), synthetic pretraining data (Phi, phi-1.5, Nemotron-4), self-improving agents and curriculum design (Meta, Karpathy’s autoresearch), and industry releases (DeepSeek’s multimodal Vision-Exp, OpenAI pricing changes). It highlights verification mechanisms (oracle tests, unit tests, registered RCTs) as the enabler of model-driven flips and frames simulation quality and verification as central to future progress, with major implications for experimentation, scientific discovery, and agentic workloads.
Receive all future signals for Greenoaks & competitors in your briefing
Never miss material M&A deals, leadership changes, account wins, or product rollouts. Polaris7 monitors 20,000+ primary sources 24/7, delivering verified telemetry directly into your executive briefing.